204 related articles for article (PubMed ID: 29129753)
1. Nitrogen mustard-induced corneal injury involves the sphingomyelin-ceramide pathway.
Charkoftaki G; Jester JV; Thompson DC; Vasiliou V
Ocul Surf; 2018 Jan; 16(1):154-162. PubMed ID: 29129753
[TBL] [Abstract][Full Text] [Related]
2. Acute corneal injury in rabbits following nitrogen mustard ocular exposure.
Goswami DG; Kant R; Ammar DA; Kumar D; Enzenauer RW; Petrash JM; Tewari-Singh N; Agarwal R
Exp Mol Pathol; 2019 Oct; 110():104275. PubMed ID: 31233733
[TBL] [Abstract][Full Text] [Related]
3. Nitrogen Mustard-Induced Corneal Injury Involves DNA Damage and Pathways Related to Inflammation, Epithelial-Stromal Separation, and Neovascularization.
Goswami DG; Tewari-Singh N; Dhar D; Kumar D; Agarwal C; Ammar DA; Kant R; Enzenauer RW; Petrash JM; Agarwal R
Cornea; 2016 Feb; 35(2):257-66. PubMed ID: 26555588
[TBL] [Abstract][Full Text] [Related]
4. An Engineered Human Fibroblast Growth Factor-1 Derivative, TTHX1114, Ameliorates Short-term Corneal Nitrogen Mustard Injury in Rabbit Organ Cultures.
Eveleth DD; Eveleth JJ; Subramaniam A; Hahn R; Zhou P; Gordon MK; Bradshaw RA
Invest Ophthalmol Vis Sci; 2018 Sep; 59(11):4720-4730. PubMed ID: 30267094
[TBL] [Abstract][Full Text] [Related]
5. Nitrogen Mustard-Induced Ex Vivo Human Cornea Injury Model and Therapeutic Intervention by Dexamethasone.
Mishra N; Kant R; Kandhari K; Ammar DA; Tewari-Singh N; Pantcheva MB; Petrash JM; Agarwal C; Agarwal R
J Pharmacol Exp Ther; 2024 Jan; 388(2):484-494. PubMed ID: 37474260
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of anti-inflammatory, antibiotic and pleiotropic agents in reversing nitrogen mustard-induced injury in ex vivo cultured rabbit cornea.
Goswami DG; Kant R; Tewari-Singh N; Agarwal R
Toxicol Lett; 2018 Sep; 293():127-132. PubMed ID: 29174984
[TBL] [Abstract][Full Text] [Related]
7. Dose-dependent emergence of acute and recurrent corneal lesions in sulfur mustard-exposed rabbit eyes.
McNutt PM; Kelly KEM; Altvater AC; Nelson MR; Lyman ME; O'Brien S; Conroy MT; Ondeck CA; Bodt SML; Wolfe SE; Schulz SM; Kniffin DM; Hall NB; Hamilton TA
Toxicol Lett; 2021 May; 341():33-42. PubMed ID: 33497768
[TBL] [Abstract][Full Text] [Related]
8. Time-dependent in situ structural and cellular aberrations in rabbit cornea in vivo after mustard gas exposure.
Sinha NR; Tripathi R; Balne PK; Green SL; Sinha PR; Bunyak F; Giuliano EA; Chaurasia SS; Mohan RR
Exp Eye Res; 2022 Nov; 224():109247. PubMed ID: 36113569
[TBL] [Abstract][Full Text] [Related]
9. Dexamethasone sodium phosphate loaded nanoparticles for prevention of nitrogen mustard induced corneal injury.
Poudel S; Kaffash E; Zhao L; Pangeni R; Chow WN; Xu Q
Exp Eye Res; 2024 Jun; 243():109902. PubMed ID: 38641196
[TBL] [Abstract][Full Text] [Related]
10. Research models of sulfur mustard- and nitrogen mustard-induced ocular injuries and potential therapeutics.
Mishra N; Agarwal R
Exp Eye Res; 2022 Oct; 223():109209. PubMed ID: 35961426
[TBL] [Abstract][Full Text] [Related]
11. Insights into mustard gas keratopathy- characterizing corneal layer-specific changes in mice exposed to nitrogen mustard.
Alemi H; Dehghani S; Forouzanfar K; Surico PL; Narimatsu A; Musayeva A; Sharifi S; Wang S; Dohlman TH; Yin J; Chen Y; Dana R
Exp Eye Res; 2023 Nov; 236():109657. PubMed ID: 37722586
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of corneal and limbal cytokines and chemokines throughout the clinical course of sulfur mustard induced ocular injury in the rabbit model.
Horwitz V; Dachir S; Cohen M; Gutman H; Cohen L; Gez R; Buch H; Kadar T; Gore A
Exp Eye Res; 2018 Dec; 177():145-152. PubMed ID: 30114412
[TBL] [Abstract][Full Text] [Related]
13. Effect of dexamethasone treatment at variable therapeutic windows in reversing nitrogen mustard-induced corneal injuries in rabbit ocular in vivo model.
Goswami DG; Mishra N; Kant R; Agarwal C; Ammar DA; Petrash JM; Tewari-Singh N; Agarwal R
Toxicol Appl Pharmacol; 2022 Feb; 437():115904. PubMed ID: 35108561
[TBL] [Abstract][Full Text] [Related]
14. Dexamethasone targets actin cytoskeleton signaling and inflammatory mediators to reverse sulfur mustard-induced toxicity in rabbit corneas.
Kant R; Mishra N; Kandhari K; Saba L; Michel C; Reisdorph R; Tewari-Singh N; Pantcheva MB; Petrash JM; Agarwal C; Agarwal R
Toxicol Appl Pharmacol; 2024 Feb; 483():116834. PubMed ID: 38266871
[TBL] [Abstract][Full Text] [Related]
15. Pathophysiology and inflammatory biomarkers of sulfur mustard-induced corneal injury in rabbits.
Goswami DG; Mishra N; Kant R; Agarwal C; Croutch CR; Enzenauer RW; Petrash MJ; Tewari-Singh N; Agarwal R
PLoS One; 2021; 16(10):e0258503. PubMed ID: 34637469
[TBL] [Abstract][Full Text] [Related]
16. Mustard Gas Exposure Actuates SMAD2/3 Signaling to Promote Myofibroblast Generation in the Cornea.
Sinha NR; Tripathi R; Balne PK; Suleiman L; Simkins K; Chaurasia SS; Mohan RR
Cells; 2023 Jun; 12(11):. PubMed ID: 37296653
[TBL] [Abstract][Full Text] [Related]
17. Establishing a Dexamethasone Treatment Regimen To Alleviate Sulfur Mustard-Induced Corneal Injuries in a Rabbit Model.
Mishra N; Kant R; Kandhari K; Tewari-Singh N; Anantharam P; Croutch CR; Pantcheva MB; Petrash JM; Araj H; Agarwal C; Agarwal R
J Pharmacol Exp Ther; 2024 Jan; 388(2):469-483. PubMed ID: 37316330
[TBL] [Abstract][Full Text] [Related]
18. Metabolomics for identifying pathways involved in vesicating agent lewisite-induced corneal injury.
Mishra N; Kant R; Goswami DG; Petrash JM; Agarwal C; Tewari-Singh N; Agarwal R
Exp Eye Res; 2023 Nov; 236():109672. PubMed ID: 37797797
[TBL] [Abstract][Full Text] [Related]
19. Doxycycline hydrogels as a potential therapy for ocular vesicant injury.
Gordon MK; Desantis A; Deshmukh M; Lacey CJ; Hahn RA; Beloni J; Anumolu SS; Schlager JJ; Gallo MA; Gerecke DR; Heindel ND; Svoboda KK; Babin MC; Sinko PJ
J Ocul Pharmacol Ther; 2010 Oct; 26(5):407-19. PubMed ID: 20925577
[TBL] [Abstract][Full Text] [Related]
20. The generation of 4-hydroxynonenal, an electrophilic lipid peroxidation end product, in rabbit cornea organ cultures treated with UVB light and nitrogen mustard.
Zheng R; Po I; Mishin V; Black AT; Heck DE; Laskin DL; Sinko PJ; Gerecke DR; Gordon MK; Laskin JD
Toxicol Appl Pharmacol; 2013 Oct; 272(2):345-55. PubMed ID: 23845594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
